Marks & Spencer Group plc buy krebskrebs
Start price
29.06.20
/
50%
€1.13
Target price
04.11.21
€1.40
Performance (%)
99.82%
End price
05.11.21
€2.26
Summary
This prediction ended on 05.11.21 with a price of €2.26. The BUY prediction by krebskrebs for Marks & Spencer Group plc saw massive gains of 99.82%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Marks & Spencer Group plc | 2.262% | 2.262% | 14.488% | 100.177% |
| iShares Core DAX® | 2,48 % | 1,74 % | 6,88 % | 55,58 % |
| iShares Nasdaq 100 | -0,98 % | -2,74 % | 33,97 % | 86,28 % |
| iShares Nikkei 225® | -4,89 % | 1,34 % | 57,02 % | 72,65 % |
| iShares S&P 500 | 1,06 % | 0,05 % | 25,18 % | 65,84 % |
Comments by krebskrebs for this prediction
In the thread Marks & Spencer Group plc diskutieren
Buy mit Kursziel 1,4
In the thread Trading Marks & Spencer Group plc
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

